References
DiMasi, J. A. & Faden, L. B. Competitiveness in follow-on drug R&D: a race or imitation? Nature Rev. Drug Discov. 10, 23–27 (2011).
Agrawal, V. & Jamwal, S. Top ten global pharma. World Pharmaceutical Frontiers [online], (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors are all employeees of GlaxoSmithKline.
Related links
FURTHER INFORMATION
Supplementary information
Supplementary information S1 (table)
(XLSX 79 kb)
Rights and permissions
About this article
Cite this article
Agarwal, P., Sanseau, P. & Cardon, L. Novelty in the target landscape of the pharmaceutical industry. Nat Rev Drug Discov 12, 575–576 (2013). https://doi.org/10.1038/nrd4089
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4089
- Springer Nature Limited
This article is cited by
-
Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications
Nature Reviews Drug Discovery (2018)
-
A comprehensive map of molecular drug targets
Nature Reviews Drug Discovery (2017)
-
Changing R&D models in research-based pharmaceutical companies
Journal of Translational Medicine (2016)
-
Systematic Analysis of Drug Targets Confirms Expression in Disease-Relevant Tissues
Scientific Reports (2016)
-
Selective Negative Allosteric Modulation Of Metabotropic Glutamate Receptors – A Structural Perspective of Ligands and Mutants
Scientific Reports (2015)